These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

568 related items for PubMed ID: 27572391

  • 21. Multistage and transmission-blocking targeted antimalarials discovered from the open-source MMV Pandemic Response Box.
    Reader J, van der Watt ME, Taylor D, Le Manach C, Mittal N, Ottilie S, Theron A, Moyo P, Erlank E, Nardini L, Venter N, Lauterbach S, Bezuidenhout B, Horatscheck A, van Heerden A, Spillman NJ, Cowell AN, Connacher J, Opperman D, Orchard LM, Llinás M, Istvan ES, Goldberg DE, Boyle GA, Calvo D, Mancama D, Coetzer TL, Winzeler EA, Duffy J, Koekemoer LL, Basarab G, Chibale K, Birkholtz LM.
    Nat Commun; 2021 Jan 11; 12(1):269. PubMed ID: 33431834
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Novel Plasmodium falciparum metabolic network reconstruction identifies shifts associated with clinical antimalarial resistance.
    Carey MA, Papin JA, Guler JL.
    BMC Genomics; 2017 Jul 19; 18(1):543. PubMed ID: 28724354
    [Abstract] [Full Text] [Related]

  • 24. Drug discovery: Priming the antimalarial pipeline.
    Fidock DA.
    Nature; 2010 May 20; 465(7296):297-8. PubMed ID: 20485420
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Identifying antimalarial compounds targeting dihydrofolate reductase-thymidylate synthase (DHFR-TS) by chemogenomic profiling.
    Aroonsri A, Akinola O, Posayapisit N, Songsungthong W, Uthaipibull C, Kamchonwongpaisan S, Gbotosho GO, Yuthavong Y, Shaw PJ.
    Int J Parasitol; 2016 Jul 20; 46(8):527-35. PubMed ID: 27150044
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Probing the Open Global Health Chemical Diversity Library for Multistage-Active Starting Points for Next-Generation Antimalarials.
    Abraham M, Gagaring K, Martino ML, Vanaerschot M, Plouffe DM, Calla J, Godinez-Macias KP, Du AY, Wree M, Antonova-Koch Y, Eribez K, Luth MR, Ottilie S, Fidock DA, McNamara CW, Winzeler EA.
    ACS Infect Dis; 2020 Apr 10; 6(4):613-628. PubMed ID: 32078764
    [Abstract] [Full Text] [Related]

  • 30. Biological characterization of chemically diverse compounds targeting the Plasmodium falciparum coenzyme A synthesis pathway.
    Fletcher S, Lucantoni L, Sykes ML, Jones AJ, Holleran JP, Saliba KJ, Avery VM.
    Parasit Vectors; 2016 Nov 17; 9(1):589. PubMed ID: 27855724
    [Abstract] [Full Text] [Related]

  • 31. The Medicines for Malaria Venture Malaria Box contains inhibitors of protein secretion in Plasmodium falciparum blood stage parasites.
    Looker O, Dans MG, Bullen HE, Sleebs BE, Crabb BS, Gilson PR.
    Traffic; 2022 Sep 17; 23(9):442-461. PubMed ID: 36040075
    [Abstract] [Full Text] [Related]

  • 32. The malaria parasite cation ATPase PfATP4 and its role in the mechanism of action of a new arsenal of antimalarial drugs.
    Spillman NJ, Kirk K.
    Int J Parasitol Drugs Drug Resist; 2015 Dec 17; 5(3):149-62. PubMed ID: 26401486
    [Abstract] [Full Text] [Related]

  • 33. The Nonartemisinin Sesquiterpene Lactones Parthenin and Parthenolide Block Plasmodium falciparum Sexual Stage Transmission.
    Balaich JN, Mathias DK, Torto B, Jackson BT, Tao D, Ebrahimi B, Tarimo BB, Cheseto X, Foster WA, Dinglasan RR.
    Antimicrob Agents Chemother; 2016 Apr 17; 60(4):2108-17. PubMed ID: 26787692
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Antimalarial drug discovery - the path towards eradication.
    Burrows JN, Burlot E, Campo B, Cherbuin S, Jeanneret S, Leroy D, Spangenberg T, Waterson D, Wells TN, Willis P.
    Parasitology; 2014 Jan 17; 141(1):128-39. PubMed ID: 23863111
    [Abstract] [Full Text] [Related]

  • 38. Disrupting malaria parasite AMA1-RON2 interaction with a small molecule prevents erythrocyte invasion.
    Srinivasan P, Yasgar A, Luci DK, Beatty WL, Hu X, Andersen J, Narum DL, Moch JK, Sun H, Haynes JD, Maloney DJ, Jadhav A, Simeonov A, Miller LH.
    Nat Commun; 2013 Jan 17; 4():2261. PubMed ID: 23907321
    [Abstract] [Full Text] [Related]

  • 39. Discovery of carbohybrid-based 2-aminopyrimidine analogues as a new class of rapid-acting antimalarial agents using image-based cytological profiling assay.
    Lee S, Lim D, Lee E, Lee N, Lee HG, Cechetto J, Liuzzi M, Freitas-Junior LH, Song JS, Bae MA, Oh S, Ayong L, Park SB.
    J Med Chem; 2014 Sep 11; 57(17):7425-34. PubMed ID: 25137549
    [Abstract] [Full Text] [Related]

  • 40. Antimalarial activity of the anticancer and proteasome inhibitor bortezomib and its analog ZL3B.
    Reynolds JM, El Bissati K, Brandenburg J, Günzl A, Mamoun CB.
    BMC Clin Pharmacol; 2007 Oct 23; 7():13. PubMed ID: 17956613
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 29.